Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume

Diabetologia

Volumn 50, Issue 8, 2007, Pages 1763-1769

  Wessels, A M ^a   Rombouts, S A R B ^b,c   Remijnse, P L ^a   Boom, Y ^a   Scheltens, P ^a   Barkhof, F ^a   Heine, R J ^a   Snoek, F J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Cognitive performance; Grey matter volume; Microvascular disease; Type 1 diabetes; White matter volume

Indexed keywords

ADULT; ARTICLE; ATTENTION; BRAIN TISSUE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GRAY MATTER; HUMAN; INFORMATION PROCESSING; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROANGIOPATHY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETINOPATHY; WHITE MATTER;

ADULT; ANALYSIS OF VARIANCE; BRAIN; COGNITION; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 34447119694     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0714-0     Document Type: Article

References (50)

1. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28:726-735
2. Wredling R, Levander S, Adamson U, Lins PE (1990) Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man. Diabetologia 33:152-157
3. Langan SJ, Deary IJ, Hepburn DA, Frier BM (1991) Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia 34:337-344
4. Deary IJ, Crawford JR, Hepburn DA, Langan SJ, Blackmore LM, Frier BM (1993) Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes 42:341-344
5. Lincoln NB, Faleiro RM, Kelly C, Kirk BA, Jeffcoate WJ (1996) Effect of long-term glycemic control on cognitive function. Diabetes Care 19:656-658
6. Hershey T, Craft S, Bhargava N, White NH (1997) Memory and insulin dependent diabetes mellitus (IDDM): effects of childhood onset and severe hypoglycemia. J Int Neuropsychol Soc 3:509-520
7. Perros P, Deary IJ, Sellar RJ, Best JJ, Frier BM (1997) Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 20:1013-1018
8. Group TDCaCTR (1996) Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 124:379-388
9. Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U (1991) Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 230:101-108
10. Austin EJ, Deary IJ (1999) Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data. Diabetes Care 22:1273-1277
11. Ryan CM, Williams TM, Orchard TJ, Finegold DN (1992) Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes 41:107-113
12. Ryan CM, Geckle MO, Orchard TJ (2003) Cognitive efficiency declines over time in adults with type 1 diabetes: effects of micro- and macrovascular complications. Diabetologia 46:940-948
13. Ferguson SC, Blane A, Perros P et al (2003) Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 52:149-156
14. Wessels AM, Rombouts SA, Simsek S et al (2006) Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study. Diabetes 55:334-340
15. Wessels AM, Simsek S, Remijnse PL et al (2006) Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 49:2474-2480
16. Dejgaard A, Gade A, Larsson H, Balle V, Parving A, Parving HH (1991) Evidence for diabetic encephalopathy. Diabet Med 8:162-167
17. Yousem DM, Tasman WS, Grossman RI (1991) Proliferative retinopathy: absence of white matter lesions at MR imaging. Radiology 179:229-230
18. Araki Y, Nomura M, Tanaka H et al (1994) MRI of the brain in diabetes mellitus. Neuroradiology 36:101-103
19. Lunetta M, Damanti AR, Fabbri G, Lombardo M, Di Mauro M, Mughini L (1994) Evidence by magnetic resonance imaging of cerebral alterations of atrophy type in young insulin-dependent diabetic patients. J Endocrinol Investig 17:241-245
20. Musen G, Lyoo IK, Sparks CR et al (2006) Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55:326-333
21. Sanfilipo MP, Benedict RH, Weinstock-Guttman B, Bakshi R (2006) Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 66:685-692
22. Zivadinov R, Sepcic J, Nasuelli D et al (2001) A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 70:773-780
23. Benedict RH, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R (2004) Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 61:226-230
24. Benedict RH, Carone DA, Bakshi R (2004) Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J Neuroimaging 14:36S-45S
25. World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. WHO, Geneva
26. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK (1995) Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia 38:437-444
27. The Diabetes Control and Complications Trial Research Group (1997) Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46:271-286
28. Cox DJ, Kovatchev BP, Gonder-Frederick LA et al (2005) Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care 28:71-77
29. Lezak MD, Howieson DB, Loring DW (2004) Neuropsychological assessment. Oxford University Press, New York
30. Wechsler D (1981) Manual of the Wechsler Adult Intelligence Scale-Revised. The Psychological Corporation Limited, New York
31. Saan RJ, Deelman BG (1986) New version of 15 words test (15WTA and 15WTB). In: Bauma AMJ, Lindeboom J (eds) Neuro-psychological diagnostics handbook. Swets & Zeitlinger, Amsterdam, pp 13-28
32. Myers JE MK (1995) Rey complex figure test. Psychological Assessment Resources, Odessa
33. Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271-276
34. Golden CJ (1978) Stroop colour word test. In: Golden CJ (ed) A manual for clinical and experimental uses. Stoelting, Chicago
35. Jensen AR, Rohwer WD (1966) The stroop color-word test: a review. Acta Psychologica 25:36-93
36. Brickenkamp R (1962) The d2 test of Attention. 1st edition. Gottingen: Hogrefe (publication in German)
37. Luteijn F, van der Ploeg FAE (1983) Groninger intelligence test: manual. Swets & Zeitlinger, Lisse (publication in Dutch)
38. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G (1993) Wisconsin card sorting test manual: revised and expanded (WCST). Psychological Assessment Resources (PAR), Odessa
39. Wechsler D (1971) Manual of the Wechsler intelligence scale for children. The Psychological Corporation, New York
40. Thurstone LL, Thurstone TG (1962) Primary mental abilities. University of Chicago Press, Chicago
41. Austin MP, Mitchell P, Goodwin GM (2001) Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 178:200-206
42. Tiemeier H (2003) Biological risk factors for late life depression. Eur J Epidemiol 18:745-750
43. Bouma J, Ranchor AV, Sanderman R, van Sonderen E (1995) Assessing symptoms of depression using the CES-D. A manual. NCG, Rijksuniversiteit Groningen, Groningen (publication in Dutch)
44. Radloff L (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:185-401
45. Filley C (2001) The behavioral neurology of white matter. Oxford University Press, New York
46. Dow C, Seidenberg M, Hermann B (2004) Relationship between information processing speed in temporal lobe epilepsy and white matter volume. Epilepsy Behav 5:919-925
47. Ryan CM (2005) Diabetes, aging, and cognitive decline. Neurobiol Aging 26(Suppl 1):21-25
48. Wong TY, Klein R, Sharrett AR et al (2002) Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 288:67-74
49. Ashburner J, Friston KJ (2000) Voxel-based morphometry-the methods. Neuroimage 11:805-821
50. De Bie SE (1987) Standaardvragen 1987: Standard questions 1987: Proposal for standardisation of questions regarding background variables and interviews. Leiden University Press, Leiden (publication in Dutch)